Seeking Alpha

Seattle Genetics (SGEN -3.1%) expands a partnership with Abbott (ABT -1.1%) in which the latter...

Seattle Genetics (SGEN -3.1%) expands a partnership with Abbott (ABT -1.1%) in which the latter will pay Seattle an upfront fee of $25M to use its antibody-drug conjugate to help develop treatments for cancer. Seattle will also receive maintenance fees and research support payments, up to $220M in milestones, and royalties (PR.)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)